OTC Markets OTCQB USD

Oncotelic Therapeutics, Inc. (OTLC)

Compare
0.0390 0.0000 (0.00%)
At close: June 11 at 3:41 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
Total Revenue
70.0000
70.0000
--
--
1,740.8550
--
Operating Expense
537.9750
634.8690
5,610.5740
9,125.8830
9,325.5890
--
Operating Income
-467.9750
-564.8690
-5,610.5740
-9,125.8830
-7,584.7340
--
Net Non Operating Interest Income Expense
-885.2170
-1,044.7860
-2,971.0460
-2,002.8130
-1,998.3210
--
Other Income Expense
-6,722.0040
-6,596.4100
13,258.2230
611.4060
-388.7510
--
Pretax Income
-8,075.1960
-8,206.0650
4,676.6030
-10,517.2900
-9,971.8060
--
Net Income Common Stockholders
-7,786.3500
-7,903.0930
5,094.9810
-9,391.0420
-9,502.6020
--
Diluted NI Available to Com Stockholders
-7,786.3500
-7,903.0930
5,094.9810
-9,391.0420
-9,502.6020
--
Basic EPS
-0.02
--
0.01
-0.03
-0.11
-0.11
Diluted EPS
-0.02
--
0.01
-0.03
-0.11
-0.11
Basic Average Shares
397,920.3730
--
384,075.3690
303,078.5480
88,099.7870
59,958.4060
Diluted Average Shares
397,920.3730
--
457,299.8900
303,078.5480
88,099.7870
59,958.4060
Total Operating Income as Reported
-6,551.1210
-6,648.0150
-9,721.6530
-9,125.8830
-7,584.7340
--
Total Expenses
537.9750
634.8690
5,610.5740
9,125.8830
9,325.5890
--
Net Income from Continuing & Discontinued Operation
-7,786.3500
-7,903.0930
5,094.9810
-9,391.0420
-9,502.6020
--
Normalized Income
-1,051.8080
-1,234.4370
-4,957.5620
-10,002.4480
-9,113.8510
--
Interest Income
--
--
--
--
--
0.1230
Interest Expense
885.2170
1,044.7860
2,971.0460
2,002.8130
1,998.3210
--
Net Interest Income
-885.2170
-1,044.7860
-2,971.0460
-2,002.8130
-1,998.3210
--
EBIT
-7,189.9790
-7,161.2790
7,647.6490
-8,514.4770
-7,973.4850
--
EBITDA
-7,189.9790
-7,161.2790
7,660.4900
-8,452.9640
-7,609.2730
--
Reconciled Depreciation
--
--
12.8410
61.5130
364.2120
--
Net Income from Continuing Operation Net Minority Interest
-7,786.3500
-7,903.0930
5,094.9810
-9,391.0420
-9,502.6020
--
Total Unusual Items Excluding Goodwill
-6,734.5420
-6,668.6560
12,724.7380
611.4060
-388.7510
--
Total Unusual Items
-6,734.5420
-6,668.6560
12,724.7380
611.4060
-388.7510
--
Normalized EBITDA
-455.4370
-492.6230
-5,064.2480
-9,064.3700
-7,220.5220
--
Tax Rate for Calcs
--
--
0.0002
--
--
--
Tax Effect of Unusual Items
--
--
2,672.1950
--
--
--
12/31/2019 - 8/26/1993

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

CRPOF Ceapro Inc.
0.1700
0.00%
 
APLIF Appili Therapeutics Inc.
0.0290
0.00%
 
KTTAW Pasithea Therapeutics Corp.
0.0158
+17.91%
 
MBXBF Microbix Biosystems Inc.
0.2535
0.00%
 
CVALF Covalon Technologies Ltd.
1.5400
0.00%
 
SRBCF Sirona Biochem Corp.
0.0536
0.00%
 
YECO EV Biologics, Inc.
0.5121
-7.58%
 
BIOAF Bioasis Technologies Inc.
0.0040
0.00%
 
EVLO Evelo Biosciences, Inc.
0.0600
+50.00%
 
ONCSQ OncoSec Medical Incorporated
0.0001
0.00%